19
PENGGUNAAN COXIB DALAM TATA LAKSANA NYERI NOSISEPTIF by Thomas Eko P Submission date: 05-Dec-2018 09:33AM (UTC+0700) Submission ID: 1050835142 File name: Medicina_Coxib_Final.pdf (154.35K) Word count: 4515 Character count: 28073

NOSISEPTIF TATA LAKSANA NYERI ... - repositori.unud.ac.id filePENGGUNAAN COXIB DALAM TATA LAKSANA NYERI NOSISEPTIF ORIGINALITY REPORT PRIMARY SOURCES arthritis.pure.elsevier.com Internet

Embed Size (px)

Citation preview

PENGGUNAAN COXIB DALAMTATA LAKSANA NYERI

NOSISEPTIFby Thomas Eko P

Submission date: 05-Dec-2018 09:33AM (UTC+0700)Submission ID: 1050835142File name: Medicina_Coxib_Final.pdf (154.35K)Word count: 4515Character count: 28073

18%SIMILARITY INDEX

17%INTERNET SOURCES

14%PUBLICATIONS

12%STUDENT PAPERS

1 1%

2 1%

3 1%

4 1%

5 1%

6 1%

7 1%

PENGGUNAAN COXIB DALAM TATA LAKSANA NYERINOSISEPTIFORIGINALITY REPORT

PRIMARY SOURCES

arthritis.pure.elsevier.comInternet Source

www.moh.gov.sgInternet Source

K. Holte. "Cyclo-oxygenase 2 inhibitors and therisk of anastomotic leakage after fast-trackcolonic surgery", British Journal of Surgery,06/2009Publicat ion

text-id.123dok.comInternet Source

ampainsoc.orgInternet Source

www.medigraphic.comInternet Source

repository.maranatha.eduInternet Source

Submitted to London School of Hygiene and

8 1%

9 1%

10 1%

11 1%

12 1%

13 1%

14 1%

15 <1%

16 <1%

17 <1%

18 <1%

19 <1%

Tropical MedicineStudent Paper

www.hisro.or.thInternet Source

www.oncoline.nlInternet Source

painrussia.ruInternet Source

www.sfar.orgInternet Source

ami.info.umfcluj.roInternet Source

revue.medhyg.chInternet Source

liu.diva-portal.orgInternet Source

mrj.ima-press.netInternet Source

www.fadona.orgInternet Source

www.alrf.asso.frInternet Source

www.paginamedicala.roInternet Source

20 <1%

21 <1%

22 <1%

23 <1%

24 <1%

25 <1%

26 <1%

27 <1%

www.actipatch.comInternet Source

Submitted to University of Louisiana at MonroeStudent Paper

Rioko Kimiko Sakata, Marcelo HenriqueGomes Nunes. "Analgesics use for kidneyfailure", Revista Dor, 2014Publicat ion

www.sbu.seInternet Source

www.drugs.comInternet Source

www.gp220.ruInternet Source

Parida, Sheetal, Aditya Parekh, Goutam Dey,Sukhen C Ghosh, and Mahitosh Mandal."Molecular inhibition of prostaglandin E2 withGW627368X: Therapeutic potential andpreclinical safety assessment in mousesarcoma model", Cancer Biology & Therapy,2015.Publicat ion

U. S. Akarca. "Gastrointestinal Effects ofSelective and Non-Selective Non-SteroidalAnti- Inflammatory Drugs", Current

28 <1%

29 <1%

30 <1%

31 <1%

32 <1%

33 <1%

34 <1%

35 <1%

36 <1%

Pharmaceutical Design, 05/01/2005Publicat ion

"COX-2 inhibitors (coxibs)", Elsevier BV, 2016Publicat ion

www.pharmacyjobs.co.ukInternet Source

www.growlife.comInternet Source

www.koreascience.or.krInternet Source

ichastaliklaridergisi.orgInternet Source

iv.iiarjournals.orgInternet Source

www.ema.europa.euInternet Source

bdigital.ufp.ptInternet Source

Strand, V.. "Are COX-2 inhibitors preferable tonon-selective non-steroidal anti-inflammatorydrugs in patients with risk of cardiovascularevents taking low-dose aspirin?", The Lancet,20071222/20080104Publicat ion

37 <1%

38 <1%

39 <1%

40 <1%

41 <1%

42 <1%

43 <1%

Exclude quotes On

Exclude bibliography On

Exclude matches < 5 words

edoc.siteInternet Source

Weatherall, M.. "Inconsistencies incardiovascular data from COX-2 inhibitor trials--is it a class effect?", JRSM, 2006.Publicat ion

www.kesimpulan.comInternet Source

www.jpp.krakow.plInternet Source

Stacy, Zachary A, Paul P Dobesh, and Toby CTrujillo. "Cardiovascular Risks ofCyclooxygenase Inhibition", PharmacotherapyThe Journal of Human Pharmacology and DrugTherapy, 2006.Publicat ion

Arzneiverordnungs- Report 2014, 2014.Publicat ion

www.ijp-online.comInternet Source

FINAL GRADE

/0

PENGGUNAAN COXIB DALAM TATA LAKSANA NYERINOSISEPTIFGRADEMARK REPORT

GENERAL COMMENTS

Instructor

PAGE 1

PAGE 2

PAGE 3

PAGE 4

PAGE 5

PAGE 6

PAGE 7

PAGE 8

PAGE 9

PAGE 10

PAGE 11

PAGE 12